Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2013
03/07/2013US20130059361 Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) Cholesterol
03/07/2013US20130059351 Thioesterase and a Method of Producing Fatty Acids or Lipids Using the Thioesterase
03/07/2013US20130059350 Constructs and methods for increasing yield of fatty alcohols in cyanobacteria
03/07/2013US20130059348 Novel amidase, gene for the same, vector, transformant, and method for production of optically active carboxylic acid amide and optically active carboxylic acid by using any one of those items
03/07/2013US20130059344 Transcription terminator sequences
03/07/2013US20130059342 Compositions and methods for use in recombinational cloning of nucelic acids
03/07/2013US20130059341 Method for producing glucuronic acid conjugate using saccharomyces cerevisiae
03/07/2013US20130059338 Artificial entropic bristle domain sequences and their use in recombinant protein production
03/07/2013US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin
03/07/2013US20130059334 Production of recombinant selenoprotein mutants with enhanced catalytic activity
03/07/2013US20130059318 Anti-iga1 antibody
03/07/2013US20130059315 Alpha-Amylase Mutants
03/07/2013US20130059312 Methods Of Using Chimeric Receptors to Identify Autoimmune Disease
03/07/2013US20130059311 Method for the identification of memory modulating compounds by assessing kibra expression
03/07/2013US20130059309 Dopaminergic Neurons Derived From Induced Pluripotent Stem Cells and Method of Making Same
03/07/2013US20130059298 Composition and Method for Treatment of Tumors
03/07/2013US20130059289 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
03/07/2013US20130059061 Cucumber variety nun 5543 cup
03/07/2013US20130059034 Polypeptide shaving transgalactosylating activity
03/07/2013US20130058971 Innoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides
03/07/2013US20130058966 Anti-pdef antibodies and uses thereof
03/07/2013US20130058960 Compositions and methods for the diagnosis and treatment of tumor
03/07/2013US20130058955 Anti-polyubiquitin antibodies and methods of use
03/07/2013US20130058945 Antigenic GM-CSF Peptides and Antibodies to GM-CSF
03/07/2013US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis
03/07/2013US20130058937 Bispecific antigen binding molecules
03/07/2013US20130058934 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
03/07/2013US20130058927 Anti-vegf antibodies
03/07/2013US20130058897 Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
03/07/2013US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/07/2013US20130058874 Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto
03/07/2013US20130058871 Method and system for mapping synaptic connectivity using light microscopy
03/07/2013US20130058869 Prevention And Treatment Of Amyloidogenic Disease
03/07/2013US20130058864 Antibodies that bind ov064 and methods of use therefor
03/07/2013US20130056014 Factor regulating component in plant, and use thereof
03/07/2013DE102011113283A1 Erhöhung des Lipidgehaltes in Mikroalgen durch genetische Manipulation einer Triacylglycerin (TAG)-Lipase Increase in the lipid content in microalgae by genetic manipulation of a triacylglycerol (TAG) lipase
03/07/2013DE102007003670B4 Doppelt transgenes nicht menschliches Säugetier Double transgenic non-human mammal
03/07/2013CA2847527A1 Bmp peptides & methods of use
03/07/2013CA2847442A1 Mycobacterium tuberculosis porins and toxins and related methods
03/07/2013CA2847348A1 Methods for the treatment of breast cancer
03/07/2013CA2847332A1 Vaccine preparation for cancer treatment
03/07/2013CA2847283A1 Organic compositions to treat hsf1-related diseases
03/07/2013CA2847115A1 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 3a
03/07/2013CA2847113A1 Protein production method using transformed plant cells
03/07/2013CA2847061A1 Protein expression
03/07/2013CA2847020A1 Caninised tumour necrosis factor antibodies and methods of using the same
03/07/2013CA2846690A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
03/07/2013CA2846290A1 Engineered sequences to facilitate expression of antigens in neisseria and methods of use
03/07/2013CA2846233A1 Compositions and methods for high fidelity assembly of nucleic acids
03/07/2013CA2846218A1 Peptides
03/07/2013CA2845598A1 Protein synthesis kit, and method for protein expression and purification using automatic purification equipment
03/07/2013CA2844421A1 Novel cellobiohydrolase enzymes
03/06/2013EP2565649A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
03/06/2013EP2565278A1 Method for the delivery of oligonucleotides
03/06/2013EP2565274A1 New malonate decarboxylases for industrial applications
03/06/2013EP2565273A1 New malonate decarboxylases for industrial applications
03/06/2013EP2565271A1 Threonine synthase from Nicotiana tabacum and methods and uses thereof
03/06/2013EP2565270A1 Method for determination of onset risk of glaucoma
03/06/2013EP2565269A1 High-purity soluble thrombomodulin and method for producing same
03/06/2013EP2565268A1 Novel muc1 antibody
03/06/2013EP2565267A1 Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity
03/06/2013EP2565266A1 Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity
03/06/2013EP2565265A1 Isopropylmalate synthase from Nicotiana tabacum and methods and uses thereof
03/06/2013EP2565262A1 Protein expression
03/06/2013EP2565260A2 Automatic biological sample purification device having a magnetic-field-applying unit, a method for extracting a target substance from a biological sample, and a protein expression and purification method
03/06/2013EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections
03/06/2013EP2564695A1 Animal models and therapeutic molecules
03/06/2013EP2563927A1 L-lactate production in cyanobacteria
03/06/2013EP2563923A2 Compositions and methods for reduced scarring and for treatment of fibrosis
03/06/2013EP2563922A1 Nucleic acid compounds with conformationally restricted monomers and uses thereof
03/06/2013EP2563921A1 Method for modulating double-strand break-induced homologous recombination
03/06/2013EP2563920A1 Modulation of transthyretin expression
03/06/2013EP2563919A1 Tumor-specific promoter and oncolytic virus vector comprising the same
03/06/2013EP2563918A1 Genome editing of a rosa locus using zinc-finger nucleases
03/06/2013EP2563915A1 I-crei variants with new specificity and methods of their generation
03/06/2013EP2563912A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
03/06/2013EP2563911A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
03/06/2013EP2563907A2 Methods for generating cardiomyocytes
03/06/2013EP2563817A2 Fluorescent fusion polypeptides and methods of use
03/06/2013EP2563802A1 Compositions and methods for the modification of gene transcription
03/06/2013EP2563513A1 A non contact real time micro polymerase chain reaction system and method thereof
03/06/2013EP2563406A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
03/06/2013EP2563399A2 Use of peptides as transporters intended for the internalization of molecules of interest into target cells
03/06/2013EP2563387A1 Adenovirus vaccine vectors
03/06/2013EP2563384A2 Immunogenic compositions and methods for treating neoplasia
03/06/2013EP2563113A2 Modified pyr/pyl receptors activated by orthogonal ligands
03/06/2013EP2308977B1 Novel herbicide resistance gene
03/06/2013EP2298901B1 Novel herbicide resistance genes
03/06/2013CN102959092A Detection of target nucleic acid sequences by pto cleavage and extension assay
03/06/2013CN102959091A Highly sensitive mutated gene detection method
03/06/2013CN102959082A New compositions and methods for treatment of autoimmune and allergic diseases
03/06/2013CN102959081A Organism data processing method and device, storage medium and program
03/06/2013CN102959080A Gene introduction method
03/06/2013CN102959079A Signal peptide contained in mannose specific lectine precursor, nucleic acid to code for said signal peptide, and use thereof
03/06/2013CN102959078A Use of endogenous promoters to express heterologous proteins
03/06/2013CN102958939A Polypeptide having beta-glucosidase activity and uses thereof
03/06/2013CN102958530A Blockade of CCL18 signaling via CCR6 as therapeutic option in fibrotic diseases and cancer
03/06/2013CN102958349A Compositions and methods for enhancing resistance to northern leaf blight in maize
03/06/2013CN102958348A Methods for agrobacterium-mediated transformation of sugar cane
03/06/2013CN102952903A Primer and reagent kit capable of being used for detecting southern rice black-streaked dwarf virus (SRBSDV) as well as quantitative detection method of SRBSDV